igf-1 lr3 cross reactivity standard igf-1 assay Buy Receptor Grade (100mcg) Late-life targeting of the IGF-1

A phase I study of the oral mTOR inhibitor ridaforolimus (RIDA) in combination with the IGF-1R antibody dalotozumab (DALO) in patients (pts) with advanced solid tumors

Functional genetic variation in the anti-mllerian hormone pathway in women with polycystic ovary syndrome

The BBB makes it difficult for anti-PD drugs to enter the brain parenchyma, but there are various receptor- and carrier-mediated pathways that allow the movement of molecules as observed in the simple diffusion of lipophilic substances

These studies, however, were limited by the small number of exposed cases and the lack of adjustment for multiple statistical comparisons and confounders

beta-cell autophagy in diabetes pathogenesis